PERmixon® in LUTS Evaluation Study (PERLES)

Clinical trial NCT02121613 · COMPLETED

Trial details

NCT number: NCT02121613
Sponsor: Pierre Fabre Medicament
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)

Start date: 2014-04-01
Primary completion: 2016-06-01
Enrollment: 833

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.